Acquired Company
Pfizer acquired Seagen for $229 per share in cash for a total enterprise value of approximately $43 billion, with the acquisition completed on December 14, 2023.
Seagen Inc., a biotechnology company, develops and markets cancer treatment therapies in the United States and internationally. The company is headquartered in Bothell, Washington. Show more
21823 30TH DRIVE SE, BOTHELL, WA, UNITED STATES, 98021, USA
Market Cap
43.15B
52 Wk Range
$0.00 - $0.00
Previous Close
$228.74
Open
$228.74
Volume
N/A
Day Range
$228.74 - $228.74
Enterprise Value
0.00
Cash
428.6M
Avg Qtr Burn
-35.82M
Insider Ownership
0.81%
Institutional Own.
88.83%
Qtr Updated
09/30/23
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|